Solid Organ Transplant Recipients With Clostridioides difficile Infection Had Lower Fecal Calprotectin and Lactoferrin Levels Compared to Immunocompetent Patients: Implications for Biomarker Interpretation
- 28 July 2026
- journal article
- letter
- Published by Wiley in Transplant Infectious Disease
- Vol. 28 (5) , e70288
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Predictive value of fecal calprotectin and lactoferrin levels for negative outcomes in Clostridioides difficile infectionEuropean Journal of Clinical Microbiology & Infectious Diseases, 2023
- Clostridioides difficile infection and recurrence among 2622 solid organ transplant recipientsTransplant Infectious Disease, 2019
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)Clinical Infectious Diseases, 2018
- Faecal lactoferrin and calprotectin in patients with Clostridium difficile infection: a case–control studyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2017
- Immunosuppressive effects of tacrolimus on macrophages ameliorate experimental colitisInflammatory Bowel Diseases, 2010